• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TGF-β1 介导的 Rho 激酶激活诱导人肝星状细胞中 TGF-β2 和内皮素-1 的表达。

TGF-β1 mediated activation of Rho kinase induces TGF-β2 and endothelin-1 expression in human hepatic stellate cells.

机构信息

Inflammation Research Unit, Pfizer Global Research and Development, Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA.

出版信息

J Hepatol. 2011 Mar;54(3):521-8. doi: 10.1016/j.jhep.2010.07.026. Epub 2010 Sep 19.

DOI:10.1016/j.jhep.2010.07.026
PMID:21087804
Abstract

BACKGROUND & AIMS: TGF-β1 a key pro-fibrotic factor activates signaling via the canonical ALK/SMAD as well as the Rho GTPase pathways. Rho kinase is a major downstream effector of Rho GTPase signaling. To understand the contribution of Rho kinase activation towards the synthesis of fibrotic mediators by hepatic stellate cells (HSC), we first profiled activated HSC and fibrotic liver tissues to identify common transcripts that were most significantly up-regulated across all samples. We then applied a pharmacologic as well as a genomics approach in a TGF-β1 activated human HSC line (LX-2) to study the involvement of Rho kinase signaling in the expression of a subset of these up-regulated fibrotic genes.

METHODS

Total RNA was profiled using microarray chips. Data analysis was performed using Ingenuity Pathway Analysis software. LX-2 cells were activated with 10 ng/ml of TGF-β1 for 24 h. Activation of downstream pathways was assessed by Western blotting with phospho-specific target biomarker antibodies. Targeted knockdown of Rho kinase isoforms 1 and 2 was achieved with RNAi. Secreted levels of endothelin-1, TGF-β2, and thrombospondin-1 were measured by ELISA.

RESULTS

TGF-β1 activated Rho kinase and Smad pathways in LX-2 cells. The syntheses of endothelin-1 and TGF-β2 were significantly inhibited in TGF-β1 treated LX-2 cells, by isoform non-selective Rho kinase inhibitors. siRNA knockdown of each isoform suggested that endothelin-1 synthesis was largely mediated by the Rho kinase-1 isoform, while both isoforms contributed to the synthesis of TGF-β2.

CONCLUSIONS

The TGF-β1 mediated secretion of endothelin-1 and TGF-β2 is mediated by Rho kinase activation in human HSC.

摘要

背景与目的

TGF-β1 是一种关键的促纤维化因子,可通过经典的 ALK/SMAD 以及 Rho GTPase 信号通路激活信号。Rho 激酶是 Rho GTPase 信号的主要下游效应物。为了了解 Rho 激酶激活对肝星状细胞(HSC)合成纤维化介质的贡献,我们首先对激活的 HSC 和纤维化肝脏组织进行了分析,以确定在所有样本中上调最显著的常见转录本。然后,我们在 TGF-β1 激活的人 HSC 系(LX-2)中应用药理学和基因组学方法,研究 Rho 激酶信号在这些上调的纤维化基因子集表达中的作用。

方法

使用微阵列芯片对总 RNA 进行分析。使用 Ingenuity Pathway Analysis 软件进行数据分析。用 10ng/ml 的 TGF-β1 激活 LX-2 细胞 24 小时。用磷酸化特异性靶标生物标志物抗体通过 Western blot 检测下游途径的激活。用 RNAi 实现 Rho 激酶同工型 1 和 2 的靶向敲低。通过 ELISA 测量内皮素-1、TGF-β2 和血小板反应蛋白-1 的分泌水平。

结果

TGF-β1 激活了 LX-2 细胞中的 Rho 激酶和 Smad 途径。在 TGF-β1 处理的 LX-2 细胞中,内皮素-1 和 TGF-β2 的合成明显受到同工型非选择性 Rho 激酶抑制剂的抑制。每种同工型的 siRNA 敲低表明,内皮素-1 的合成主要由 Rho 激酶-1 同工型介导,而两种同工型都有助于 TGF-β2 的合成。

结论

TGF-β1 介导的内皮素-1 和 TGF-β2 的分泌是通过人 HSC 中 Rho 激酶的激活介导的。

相似文献

1
TGF-β1 mediated activation of Rho kinase induces TGF-β2 and endothelin-1 expression in human hepatic stellate cells.TGF-β1 介导的 Rho 激酶激活诱导人肝星状细胞中 TGF-β2 和内皮素-1 的表达。
J Hepatol. 2011 Mar;54(3):521-8. doi: 10.1016/j.jhep.2010.07.026. Epub 2010 Sep 19.
2
The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.在转化生长因子-β1处理的肝星状细胞中,表观遗传调控的微小RNA-378a靶向转化生长因子-β2 。
Cell Physiol Biochem. 2016;40(1-2):183-194. doi: 10.1159/000452536. Epub 2016 Nov 18.
3
Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis.肝星状细胞中TGF-β1-CD147正反馈环的激活促进肝纤维化。
Sci Rep. 2015 Nov 12;5:16552. doi: 10.1038/srep16552.
4
NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.NLRC5在肝纤维化过程中调节转化生长因子-β1诱导的肝星状细胞增殖和激活。
Int J Biochem Cell Biol. 2016 Jan;70:92-104. doi: 10.1016/j.biocel.2015.11.010. Epub 2015 Nov 26.
5
Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.miR-200a 在 TGF-β1 介导的肝星状细胞活化中的作用。
Mol Cell Biochem. 2014 Mar;388(1-2):11-23. doi: 10.1007/s11010-013-1895-0. Epub 2013 Nov 16.
6
RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation.用 TGF-β1 处理的 LX-2 细胞的 RNA 测序鉴定与肝星状细胞激活相关的基因。
Mol Biol Rep. 2021 Dec;48(12):7677-7688. doi: 10.1007/s11033-021-06774-3. Epub 2021 Oct 14.
7
Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.在肝纤维化中诱导 Pin1 及其在 TGF-β1 表达和 Smad2/3 磷酸化中的作用。
J Hepatol. 2014 Jun;60(6):1235-41. doi: 10.1016/j.jhep.2014.02.004. Epub 2014 Feb 13.
8
Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells.丹酚酸 B 对转化生长因子-β1 激活的大鼠肝星状细胞中 MAPK 信号通路的抑制作用。
J Ethnopharmacol. 2010 Nov 11;132(2):384-92. doi: 10.1016/j.jep.2010.05.026. Epub 2010 Jul 3.
9
TGF-β1 and TGF-β2 abundance in liver diseases of mice and men.小鼠和人类肝脏疾病中转化生长因子-β1和转化生长因子-β2的丰度。
Oncotarget. 2016 Apr 12;7(15):19499-518. doi: 10.18632/oncotarget.6967.
10
The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.表没食子儿-3-没食子酸酯在胆管结扎性胆汁淤积大鼠和人肝星状LX-2细胞中的抗纤维化作用由PI3K/Akt/Smad信号通路介导。
Acta Pharmacol Sin. 2015 Apr;36(4):473-82. doi: 10.1038/aps.2014.155. Epub 2015 Mar 16.

引用本文的文献

1
Investigation of HO-1 Regulation of Liver Fibrosis Related to Nonalcoholic Fatty Liver Disease Through the SIRT1/TGF-ß/Smad3 Pathway.通过SIRT1/TGF-β/Smad3通路研究血红素加氧酶-1对非酒精性脂肪性肝病相关肝纤维化的调控作用
J Clin Transl Hepatol. 2025 Jun 28;13(6):456-468. doi: 10.14218/JCTH.2024.00481. Epub 2025 Mar 12.
2
A pH-sensitive peptide amphiphilic-based drug delivery system inhibits hepatocellular carcinoma growth by suppressing hepatic stellate cell activation.一种基于pH敏感肽两亲物的药物递送系统通过抑制肝星状细胞活化来抑制肝细胞癌生长。
Mater Today Bio. 2025 Apr 30;32:101821. doi: 10.1016/j.mtbio.2025.101821. eCollection 2025 Jun.
3
Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis.
青蒿琥酯通过ROCK1/ATF3轴诱导肝星状细胞铁死亡并减轻肝纤维化
J Clin Transl Hepatol. 2024 Jan 28;12(1):36-51. doi: 10.14218/JCTH.2023.00162. Epub 2023 Aug 25.
4
Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy.在抗逆转录病毒治疗下,I 型干扰素和 TGF-β 合作诱导 HIV-1 感染中的肝纤维化。
JCI Insight. 2022 Jul 8;7(13):e152738. doi: 10.1172/jci.insight.152738.
5
Silencing of CD147 inhibits hepatic stellate cells activation related to suppressing aerobic glycolysis via hedgehog signaling.CD147基因沉默通过刺猬信号通路抑制有氧糖酵解,从而抑制肝星状细胞激活。
Cytotechnology. 2021 Apr;73(2):233-242. doi: 10.1007/s10616-021-00460-9. Epub 2021 Feb 18.
6
Vitamin A and Its Multi-Effects on Pancreas: Recent Advances and Prospects.维生素 A 及其对胰腺的多效作用:最新进展与展望。
Front Endocrinol (Lausanne). 2021 Feb 18;12:620941. doi: 10.3389/fendo.2021.620941. eCollection 2021.
7
Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.内皮素-1 在门静脉高压症中的作用:肝星状细胞的复杂作用。
Exp Biol Med (Maywood). 2020 Oct;245(16):1504-1512. doi: 10.1177/1535370220949148. Epub 2020 Aug 13.
8
TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation.TNF-α 通过增强 TGF-β 信号诱导内皮细胞向间充质细胞转化。
Cancer Sci. 2020 Jul;111(7):2385-2399. doi: 10.1111/cas.14455. Epub 2020 Jun 11.
9
Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats.Rho 激酶抑制剂与肽修饰白蛋白载体偶联可降低肝硬化大鼠的门静脉压力并增加肾灌注。
Sci Rep. 2019 Feb 19;9(1):2256. doi: 10.1038/s41598-019-38678-5.
10
The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells.肝硬化肝脏中二十二碳六烯酸(DHA)耗竭,DHA 是肝星状细胞中 NF-κB 和 TGFβ 途径的关键调节剂。
Cell Death Dis. 2019 Jan 8;10(1):14. doi: 10.1038/s41419-018-1243-0.